Compound information
- Natural Products
- ZC862307
- Molecular Formula
- C21H29N3O6
- Molecular Weight
- 419.205635648 g/mol
- Structure
-
- IUPAC Name
- benzyl (2R)-2-[[(1S)-1-[(2-methoxy-2-oxo-ethyl)carbamoyl]-2-methyl-propyl]carbamoyl]pyrrolidine-1-carboxylate
- InChI
- InChI=1S/C21H29N3O6/c1-14(2)18(20(27)22-12-17(25)29-3)23-19(26)16-10-7-11-24(16)21(28)30-13-15-8-5-4-6-9-15/h4-6,8-9,14,16,18H,7,10-13H2,1-3H3,(H,22,27)(H,23,26)/t16-,18+/m1/s1
- InChI Key
- TVCNPXGWXYJWMS-AEFFLSMTSA-N
- SMILES
- COC(=O)CNC(=O)[C@@H](NC(=O)[C@H]1CCCN1C(=O)OCc1ccccc1)C(C)C
- Source
- ZINC000005706854
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 114.04 Å2 | LogP | 1.903 |
LogS | -2.627 | LogD | 2.209 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.017 | Pgp substrate | 0.082 |
HIA | 0.961 | F20 % | 0.928 |
F30 % | 0.188 | Caco-2 | -4.622 |
MDCK | -4.948 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.448 | PPB | 68.435 |
VD | 0.695 | Fu | 0.934 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.436 |
CYP2A6 substrate | 0.308 | CYP2B6 substrate | 0.431 |
CYP2C19 inhibitor | 0.415 | CYP2C19 substrate | 0.612 |
CYP2C8 substrate | 0.599 | CYP2C9 inhibitor | 0.064 |
CYP2C9 substrate | 0.391 | CYP2D6 inhibitor | 0.008 |
CYP2D6 substrate | 0.33 | CYP2E1 substrate | 0.364 |
CYP3A4 inhibitor | 0.231 | CYP3A4 substrate | 0.81 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.882 | CL | 4.766 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.002 | Hepatotoxicity | 0.531 |
Mutagenicity | 0.019 | Rat Oral Acute Toxicity | 0.163 |
FDAMDD | 0.167 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.002 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.007 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.825 | IGC50 | 2.225 |
LC50FM | 2.02 | LC50DM | 4.808 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.278 | NR-AR-LBD | 0.287 |
NR-AhR | 0.002 | NR-Aromatase | 0.022 |
NR-ER | 0.266 | NR-ER-LBD | 0.376 |
NR-PPAR-gamma | 0.15 | SR-ARE | 0.079 |
SR-ATAD5 | 0.282 | SR-HSE | 0.103 |
SR-MMP | 0.011 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.